Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-20-014005
Filing Date
2020-06-26
Accepted
2020-06-26 16:49:10
Documents
1
Period of Report
2020-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3493
  Complete submission text file 0001437749-20-014005.txt   5004
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Issuer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 43334 SEVEN MILE RD. SUITE 1000 NORTHVILLE MI 48167
Business Address
MATHIESEN JEFFREY S (Reporting) CIK: 0001296853 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55242 | Film No.: 20994695